پديد آورندگان :
عليواني، آرش نويسنده Ophthalmologist, Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Alivand, Arash , فرحي، فريدون نويسنده Associate Professor of Ophthalmology, Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Farrahi, Fereydoun , استاديان، فرشاد نويسنده Assistant Professor of Ophthalmology, Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Ostadian, Farshad , فقهي ، مصطفي نويسنده Feghhei, M
چكيده لاتين :
Background: To evaluate the effect of silicone oil (SO) on bestcorrected
visual acuity in phakic and pseudophakic vitrectomizied
eyes.
Material and methods: This prospective comparative case-control
study evaluated the best-corrected visual acuity (BCVA) in SO
filled vitrectomizied eyes (case group 64 eyes) compared to the
vitrectomizied eyes without SO injection (control group 46 eyes).
The preoperative and postoperative BCVA evaluated by Snellen
chart were compared between two groups. Exclusion criteria was
consist of aphakia, any degree of anterior chamber inflammation,
SO bubbles in anterior chamber and increased intraocular pressure
in postoperative period.
Results: In the silicone oil group mean ±SD preoperative log MAR
of BCVA was 1.76 ± 0.60 compared to 1.82 ± 0.52 in control group
(P= 0.655), and mean postoperative log MAR of BCVA was 1.68 ±
0.56 compared to 1.55 ± 0.63 in control group (P = 0.23). There
were no significant differences among groups.
Conclusion: SO in vitreous cavity of phakic and pseudophakic
eyes could change vision in some of the patients. In this study,
improvement of visual outcome occurred at the end of six months
in both groups and SO per se has not been found to be an
attributable factor for reduction of BCVA in patients.